Breast cancer death rates are similar in BRCA mutation carriers and noncarriers
This article has no abstract so we have provided the first paragraph of the full text.
BRCA1-associated breast cancers are characterized by features that are associated with a poor prognosis; however, the effect of BRCA1 or BRCA2 mutations on prognosis remains unclear. A recent study by Rennert et al. compared the survival rates of breast cancer patients with and without a BRCA1 or BRCA2 mutation.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Mycobacterial virulence and specialized secretion: same story, different endingNature Medicine News and Views (01 Mar 2007)